107 Spring St
Seattle, WA, 98104 United States
(800) 351-3902 †
A development-stage company, Atossa Genetics owns and markets the MASCT (Mammary Aspirate Specimen Cytology Test) System, which was created by Atossa founder Steven Quay and tests for precursors to breast cancer. The MASCT System goes beyond mammograms in that it can detect genetic pre-cancerous conditions in the breast up to eight years before a mammography. Patented and approved by the
† Some telephone numbers on the Hoover’s site may be on a country’s do not call or do not contact list including, but not limited to, the United Kingdom’s CTPS or TPS registers. It is a legal requirement that companies do not make sales or marketing calls to registered numbers. These are central opt out registers whereby corporate subscribers and individuals can register their preference not to receive unsolicited sales and marketing telephone calls. By using the information provided on the Hoover’s sites, as the direct marketer you represent and warrant that you will use such information in compliance with all applicable local, state, national or international laws and regulations, including any local do not call registers or marketing regulations, and agree to defend, indemnify and hold harmless Dun & Bradstreet and each of its affiliates in the event your use violates such laws and regulations.